Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-03-06Clinical Trial Update: Renin-angiotensin-aldosterone System Polymorphisms in Resistant Hypertension and Adverse Cardiovascular Events
A completed clinical trial update examining the impact of renin-angiotensin-aldosterone system polymorphisms on resistant hypertension and a…
-
FDA approval · 2013-03-05FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Losartan Potassium and Hydrochlorothiazide from Lupin Pharmaceuticals, expanding its approva…
-
CLINICAL_TRIALS trial_result · 2013-03-05Clinical Trial Update: Echocardiographic Evaluation of Hypertensive Acute Pulmonary Edema
A completed clinical trial assessing echocardiographic outcomes in patients with hypertensive acute pulmonary edema.
-
EMA withdrawal · 2013-03-01EMA Withdrawn: Riprazo (aliskiren) — Novartis Europharm Ltd.
EMA has withdrawn Riprazo (aliskiren) from the market in Europe.
-
CLINICAL_TRIALS trial_result · 2013-03-01Clinical Trial Update: Improving Adherence in Patients With Hypertension - A Novel Use of Communication Technology [NA]
A completed clinical trial evaluating a novel communication-technology approach to improve medication adherence in patients with hypertensio…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-02-28FDA Approved: AVAPRO — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a Supplemental Application for AVAPRO (irbesartan) submitted by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2013-02-27FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for metoprolol tartrate from Hospira, Inc., indicating an updated regulatory action on the generic p…
-
CLINICAL_TRIALS trial_result · 2013-02-25Clinical Trial Update: Acetyl-L-Carnitine in Type 2 Diabetes [Phase 3]
A Phase 3 trial evaluating acetyl-L-carnitine in patients with type 2 diabetes mellitus, including hypertension, has completed.
-
FDA approval · 2013-02-22FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Aurobindo Pharma Limited)
The FDA approved Aurobindo Pharma Limited's original application for a generic fixed-dose combination of irbesartan and hydrochlorothiazide …
-
FDA approval · 2013-02-21FDA Approved: ATACAND — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for ATACAND (candesartan cilexetil) filed by ANI Pharmaceuticals, Inc., updating its labeling.
-
FDA approval · 2013-02-20FDA Approved: LISINOPRIL — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for lisinopril (Actavis Pharma, Inc.).
-
CLINICAL_TRIALS trial_result · 2013-02-20Clinical Trial Update: Does Ultraviolet Irradiation Reduce Platelet Reactivity and Improve Coronary Microvascular Function in Man? [NA]
A completed clinical trial investigated whether ultraviolet irradiation can reduce platelet reactivity and improve coronary microvascular fu…
-
CLINICAL_TRIALS trial_result · 2013-02-20Clinical Trial Update: The Influence of Red Grape Cells on Blood Pressure Vascular Function in People With Hypertension [NA]
This entry reports the completion of a clinical trial evaluating red grape cells' effects on blood pressure and vascular function. The study…
-
CLINICAL_TRIALS trial_result · 2013-02-20Clinical Trial Update: Individually Tailored Web-Based Program to Improve Blood Pressure Control [NA]
The clinical trial evaluating a tailored web-based program to improve blood pressure control has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: The Antihypertensives and Vascular, Endothelial and Cognitive Function Trial [Phase 2]
Phase 2 trial evaluating the impact of antihypertensive therapy on vascular endothelial function and cognitive outcomes in older adults with…
-
CLINICAL_TRIALS trial_result · 2013-02-12Clinical Trial Update: Diameters and Wall-to-lumen Ratio of Retinal Arterioles in Patients With Retinal Vein Occlusion. [NA]
This is a completed clinical trial update examining diameters and wall-to-lumen ratio of retinal arterioles in hypertensive patients with re…
-
CLINICAL_TRIALS trial_result · 2013-02-12Clinical Trial Update: Dairy Foods and Blood Pressure in Multi-Ethnic Children [NA]
This clinical trial evaluated the relationship between dairy foods and blood pressure in multi-ethnic children. The study status is complete…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Nitric Oxide Mediated Vasodilatory Response to Hawthorn Standardized Extract [Phase 1]
A Phase 1 clinical trial assessing nitric oxide–mediated vasodilatory response to hawthorn standardized extract in adults with prehypertensi…
-
FDA label_change · 2013-02-05FDA Approved: INDAPAMIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for indapamide from Actavis Pharma, resulting in labeling changes for the product.
-
FDA approval · 2013-02-05FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Spironolactone and Hydrochlorothiazide from Mylan Pharmaceuticals Inc. (ANDA 086513).
-
FDA approval · 2013-02-01FDA Approved: AZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for AZOR (amlodipine besylate and olmesartan medoxomil) from Cosette Pharmaceuticals, Inc.
-
FDA approval · 2013-02-01FDA Approved: BENICAR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Benicar (olmesartan medoxomil) submitted by Cosette Pharmaceuticals, Inc., authorizing a change …
-
FDA approval · 2013-02-01FDA Approved: BENICAR HCT — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Benicar HCT (olmesartan medoxomil-hydrochlorothiazide) submitted by Cosette Pharmaceuticals,…
-
FDA approval · 2013-02-01FDA Approved: TRIBENZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Tribenzor (olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide) from Cosette Ph…
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: Antihypertensive Effect and Safety of Peptides Derived From Coldwater Shrimp [Phase 2]
A Phase 2 study assessing the antihypertensive effect and safety of peptides derived from coldwater shrimp in people with hypertension. The …